Improving medicines use in people who take multiple medicines

Not Applicable

Completed

• Conditions: Polypharmacy; Not Applicable

• Registration Number: ISRCTN90146150
• Lead Sponsor: niversity of Bristol

Brief Summary

2022 Protocol article in https://doi.org/10.3310/nihropenres.13285.1 (added 06/06/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-28
• Study Completion: 2023-10-03
• Last Update Posted: 6 November 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1983

Inclusion Criteria

Persons experiencing potentially problematic polypharmacy in primary care and community settings. This will specifically include hard to reach” groups, including nursing home residents, housebound individuals, and those who lack capacity to consent (e.g. dementia).
The exact patient population will be defined as part of the case finding approach to be determined by the development phase (Phase 1) of the project. It is anticipated the case finding tool will identify older people (=60 years) who are receiving 10 or more medications regularly on prescription. This is because people in this group are more likely than younger people on fewer medications to trigger at least one of the prescribing quality indicators (being defined within Phase 1) which will underpin the case finding approach.

Exclusion Criteria

1. Individuals receiving end-of-life care
2. Patients judged by their GP to have chaotic medication use (e.g. history of drug or alcohol misuse)
3. The GP deems contact to be inappropriate; for example, due to severe mental health problems, terminal illness, recent bereavement
4. Participant is unable to complete the study questionnaires or medication review appointment (either themselves or with the help of carers)
5. Individuals planning to move GP practice within the 6-month follow-up period

Study & Design

• Study Type: Interventional
• Study Design: Not specified